Recurrent uterine serous carcinoma with a germline pathogenic <i>BRCA2</i> variant treated using olaparib: A case report.

Inoue, Kayo; Tsubamoto, Hiroshi; Ueda, Tomoko; Tajima, Chihiro; Nakagomi, Nami

Recurrent uterine serous carcinoma with a germline pathogenic BRCA2 variant treated using olaparib: A case report.

Inoue, Kayo; Tsubamoto, Hiroshi; Ueda, Tomoko; Tajima, Chihiro; Nakagomi, Nami.

Afiliação

Inoue K; Department of Obstetrics and Gynecology, Hyogo College of Medicine, Japan.
Tsubamoto H; Department of Obstetrics and Gynecology, Hyogo College of Medicine, Japan.
Ueda T; Department of Obstetrics and Gynecology, Hyogo College of Medicine, Japan.
Tajima C; Department of Obstetrics and Gynecology, Hyogo College of Medicine, Japan.
Nakagomi N; Department of Surgical Pathology, Hyogo College of Medicine, Japan.

Gynecol Oncol Rep ; 32: 100563, 2020 May.

Article em En | MEDLINE | ID: mdl-32300630

Palavras-chave

Germline BRCA2 mutation; Olaparib; Uterine serous carcinoma

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Gynecol Oncol Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google